(Q41449189)

English

Neoadjuvant androgen suppression with radiation in the management of locally advanced adenocarcinoma of the prostate: experimental and clinical results

scientific article published on March 1997

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

30 September 2017

1 reference

Europe PubMed Central

Neoadjuvant androgen suppression with radiation in the management of locally advanced adenocarcinoma of the prostate: experimental and clinical results (English)

1 reference

Europe PubMed Central

30 September 2017

1 reference

based on heuristic

inferred from title

author name string

Zietman AL

1

1 reference

Europe PubMed Central

30 September 2017

Prince EA

2

1 reference

Europe PubMed Central

30 September 2017

Nakfoor BM

3

1 reference

Europe PubMed Central

30 September 2017

Shipley WU

4

1 reference

Europe PubMed Central

30 September 2017

language of work or name

0 references

publication date

1 March 1997

1 reference

Europe PubMed Central

30 September 2017

1 reference

Europe PubMed Central

30 September 2017

49

1 reference

Europe PubMed Central

30 September 2017

3A Suppl

1 reference

Europe PubMed Central

30 September 2017

74-83

1 reference

Europe PubMed Central

30 September 2017

Patterns of care studies: dose-response observations for local control of adenocarcinoma of the prostate.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Cancer Control following Anatomical Radical Prostatectomy: An Interim Report

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Bilateral pelvic lymphadenectomy and radical prostatectomy for clinical stage C prostatic cancer: role of adjuvant treatment for residual cancer and in disease progression

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

A ten year follow-up of 682 patients treated for prostate cancer with radiation therapy in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The prognostic significance of post-irradiation biopsy results in patients with prostatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Biopsy after External Beam Radiation Therapy for Adenocarcinoma of the Prostate: Correlation with Original Histological Grade and Current Prostate Specific Antigen Levels

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Serum prostate-specific antigen: the most useful tumor marker

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostate-specific antigen to determine progression-free survival after radiation therapy for localized carcinoma of prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostate-specific antigen as a pretherapy prognostic factor in patients treated with radiation therapy for clinically localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Radical radiation therapy in the management of prostatic adenocarcinoma: the initial prostate specific antigen value as a predictor of treatment outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The treatment of prostate cancer by conventional radiation therapy: an analysis of long-term outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Advanced prostate cancer: the results of a randomized comparative trial of high dose irradiation boosting with conformal protons compared with conventional dose irradiation using photons alone

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Conformal static field radiation therapy treatment of early prostate cancer versus non-conformal techniques: a reduction in acute morbidity

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Late rectal bleeding following combined X-ray and proton high dose irradiation for patients with stages T3-T4 prostate carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Conformal treatment of prostate cancer with improved targeting: superior prostate-specific antigen response compared to standard treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognosis and prostatic volume changes during endocrine management of prostate cancer: a longitudinal study

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The role of neoadjuvant hormonal manipulation in localized prostatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Intermittent androgen suppression in the treatment of prostate cancer: a preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Improved control of bulky prostate carcinoma with sequential estrogen and radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Androgen deprivation with radiation therapy compared with radiation therapy alone for locally advanced prostatic carcinoma: a randomized comparative trial of the Radiation Therapy Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Identification of intermediate-risk prostate cancer patients treated with radiotherapy suitable for neoadjuvant hormone studies

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Biochemical and pathological effects of 8 months of neoadjuvant androgen withdrawal therapy before radical prostatectomy in patients with clinically confined prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Neoadjuvant hormonal therapy improves the therapeutic ratio in patients with bulky prostatic cancer treated with three-dimensional conformal radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Radiotherapy and androgen ablation for clinically localized high-risk prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Time to second prostate-specific antigen failure is a surrogate endpoint for prostate cancer death in a prospective trial of therapy for localized disease

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0090-4295(97)00173-8

1 reference

Europe PubMed Central

30 September 2017

1 reference

Europe PubMed Central

30 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41449189&oldid=2097856912"